Oxford Nanopore Technologies PLC (4R0)

Overview

Oxford Nanopore Technologies plc stands at the forefront of the biotechnology industry, focusing on the pioneering research, development, manufacture, and commercialization of an innovative nanopore-based sequencing platform. This platform is capable of the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), catering to a global market that encompasses the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific regions. The company's operations are divided into Life Science Research Tools and Covid Testing segments, reflecting its diverse application range from scientific research to pandemic response efforts. Initially founded as Oxford NanoLabs Limited in 2005, the company rebranded to Oxford Nanopore Technologies plc in May 2008, with its headquarters located in Oxford, the United Kingdom. Its technological innovations serve a wide array of scientific and biomedical research fields, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. Through its advancements, Oxford Nanopore Technologies is contributing significantly to the global understanding and management of complex biological information.

Products and Services

• MinION: A compact, portable sequencing device designed for the analysis of DNA and RNA. This product stands out for its ease of use and portability, making advanced genetic analysis accessible outside traditional laboratory settings.
• GridION: An advanced benchtop nanopore sequencer that can run and analyse up to five MinION or Flongle flow cells simultaneously, offering flexibility and high-throughput sequencing capabilities for laboratory use.
• MinION Mk 1C: This version of the MinION combines nanapore-based sequencing technology with integrated analysis software and connectivity, facilitating a streamlined, portable sequencing solution.
• Flongle: Serving as an adapter for MinION or GridION, Flongle enables DNA sequencing or cDNA sequencing on smaller, single-use flow cells for quick and cost-effective sequencing projects.
• PromethION 2 Solo: A high-capacity sequencer capable of handling two PromethION flow cells, designed for users requiring large-scale sequencing capabilities in a compact form.
• PromethION 2, PromethION 24, and PromethION 48: A series of self-contained benchtop nanopore sequencers offering varying levels of throughput, from single to multiple users, and scaling up to terabases of sequencing data. These products cater to large-scale genomic projects and provide comprehensive solutions for high-demand sequencing environments.
• VolTRAX: An automated solution for library preparation tailored for nanopore analyses, simplifying the prep work required for sequencing and enhancing laboratory efficiency.
• Q-Line: This product range is focused on applied applications of sequencing, offering practical solutions for fields such as agriculture, environmental surveillance, and more, with a specific emphasis on applied sequencing needs.
• SAR-Cov-2 Testing Products: Oxford Nanopore Technologies has rapidly responded to the global COVID-19 pandemic by developing and offering specialized products for the testing of SARS-CoV-2, demonstrating the company's agility and commitment to public health.